Avery Dennison Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/28/24 | FY 12/30/23 | FY 12/31/22 | FY 01/01/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.9B | $8.8B | $8.4B | $9.0B | $8.4B |
| Cost of revenue | $6.3B | $6.2B | $6.1B | $6.6B | $6.1B |
| Gross profit | $2.5B | $2.5B | $2.3B | $2.4B | $2.3B |
| Selling, general & administrative | $1.4B | $1.4B | $1.3B | $1.3B | $1.2B |
| Research and development | $136.6M | $137.8M | $135.8M | $136.1M | $136.6M |
| Interest expense | $135.4M | $117.0M | $119.0M | $84.1M | $70.2M |
| Pretax income | $925.1M | $953.5M | $694.7M | $999.3M | $992.6M |
| Income tax expense | $237.1M | $248.6M | $191.7M | $242.2M | $248.6M |
| Net income | $688.0M | $704.9M | $503.0M | $757.1M | $740.1M |
| Balance Sheet | |||||
| Cash and equivalents | $202.8M | $329.1M | $215.0M | $167.2M | $162.7M |
| Current assets | $3.0B | $3.1B | $2.8B | $2.8B | $2.7B |
| Total assets | $8.8B | $8.4B | $8.2B | $8.0B | $8.0B |
| Current liabilities | $2.7B | $2.9B | $2.7B | $2.8B | $2.5B |
| Stockholders' equity | $2.2B | $2.3B | $2.1B | $2.0B | $1.9B |
| Cash Flow Statement | |||||
| Cash from operations | $881.4M | $938.8M | $826.0M | $961.0M | $1.0B |
| Depreciation and amortization | $328.2M | $312.2M | $298.4M | $290.7M | $244.1M |
| Stock-based compensation | $27.9M | $28.7M | $22.3M | $47.4M | $37.2M |
| Capital expenditure | $169.0M | $208.8M | $265.3M | $278.1M | $255.0M |
| Free cash flow | $712.4M | $730.0M | $560.7M | $682.9M | $791.8M |
| Dividends paid | $288.4M | $277.5M | $256.7M | $238.9M | $220.6M |
| Share repurchases | $572.3M | $247.5M | $137.5M | $379.5M | $180.9M |
| Impairments | $0 | $0 | $0 | — | $0 |
Shares outstanding 76.5M · Free float 99.3%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- June 4, 2026 8-K
- May 5, 2026 10-Q
- May 1, 2026 8-K
- April 28, 2026 8-K
- February 26, 2026 8-K
- February 25, 2026 10-K
- February 4, 2026 8-K
- October 28, 2025 10-Q